Abstract
Abstract
Background
People with leprosy who have been declared Release From Treatment (RFT) are often not aware of the leprosy sequelae possibility which can decrease their quality of life. This could be because they have been adapting for a long time hence they do not feel the need to see physicians. This study seeks to compare the results of Vision-Related Quality of Life (VR-QoL) among RFT persons based on the National Eye Institute Visual Functioning Questionnaire–25 (NEI-VFQ-25) and WHO grading disability based on physical examination.
Methods
A cross-sectional study of 325 RFT subjects from leprosy communities (Singkawang, West Kalimantan and Tangerang, Banten) was conducted between 2018 and 2019. We used the NEI-VFQ-25 questionnaire that had been validated and translated into Indonesian and distributed to the leprosy population. Relationships and comparisons among variables were evaluated using Kruskal–Wallis and Mann–Whitney tests.
Results
There were three main results: The median composite score of VR-QoL for WHO grade 0, 1, and 2 disabilities has decreased by 13%, 25.5%, and 30% of the maximum value, respectively. Of the total, eleven subscales were statistically significant between WHO grading disability and VR-QoL based on the NEI-VFQ-25 (p < 0.05). The comparison between grade 0 and grade 2 disability in all subscales was statistically significant (p < 0.05).
Conclusions
The grade of disability is related to their VR-QoL assessment using the NEI-VFQ-25 questionnaire. Thus, it can be used as an initial screening in primary healthcare settings to increase awareness of disability before a thorough physical examination.
Funder
Direktorat Riset and Pengembangan, Universitas Indonesia
Publisher
Springer Science and Business Media LLC
Subject
Ophthalmology,General Medicine
Reference27 articles.
1. Scollard DM, Adams LB, Gillis TP, Krahenbuhl JL, Truman RW, Williams DL. The continuing challenges of leprosy. Clin Microbiol Rev. 2006;19:338–81.
2. Lastória JC, de Abreu MAMM. Leprosy: review of the epidemiological, clinical, and etiopathogenic aspects - Part 1. An Bras Dermatol. 2014;89:205–18.
3. da Silva Viana L, de Aguiar MI, de Vasconcelos PF, de Aquino DM. Aspecto físico e as repercussôes na qualidade de vida e autonomia de idosos afetados por hanseníase. Eglobal. 2017;16:336.
4. World Health Organization Leprosy (Hansen’s disease). World Health Organization; 2021.
5. World Health Organization. Global leprosy (Hansen disease) update, 2019: time to step-up prevention initiatives. 2020;419